Literature DB >> 11738735

Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection.

Y Zhang1, M G Taylor, M V Johansen, Q D Bickle.   

Abstract

Several defined vaccine candidate antigens of Schistosoma japonicum have shown promise in large animal vaccination experiments. However, vaccination of mice in the laboratory with either single recombinant antigens or DNA encoding forms of the individual antigens has so far failed to induce significant protection against S. japonicum cercarial challenge infection as judged by worm reduction, although specific antibodies were generated. This is in contrast to the results achieved using radiation-attenuated vaccines which are highly protective. Even in large animal vaccination experiments, the protection levels obtained with single defined antigens were far below those achieved using the attenuated vaccines. One possible interpretation is that the immune responses induced by single antigen vaccination may not be strong enough to combat the challenging infection. We, therefore, carried out mouse vaccination experiments using a cocktail DNA vaccine comprising four DNA plasmids encoding four different S. japonicum antigens, Sj62, Sj28, Sj23 and Sj14-3-3, respectively. We, also investigated whether co-injection of the mouse IL-12 encoding plasmid with the cocktail DNA vaccine was able to enhance the Th1 responses and hence the protective immunity. Three intramuscular injections of the cocktail DNA vaccine induced a significant Th1-type cellular response with high level of IFN-gamma production by splenocytes upon in vitro stimulation with recombinant antigens. Importantly, significant IgG antibody responses were also induced against crude worm antigens. In two out of three experiments, significant resistance (34-37 and 44-45%, respectively) was demonstrated while another experiment did not show any protection against S. japonicum cercarial challenge infection. Co-injection of the IL-12 encoding DNA did not further enhance these responses, nor the level of resistance, compared with the cocktail DNA alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738735     DOI: 10.1016/s0264-410x(01)00420-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Michelle Paz; Rachael M Villalovos; Janet Pompa
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.

Authors:  Laura A Kerepesi; Paul B Keiser; Thomas J Nolan; Gerhard A Schad; David Abraham; Thomas B Nutman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Induction of antigen-specific CTL and antibody responses in mice by a novel recombinant tandem repeat DNA vaccine targeting at mucin 1 of pancreatic cancer.

Authors:  Wen-Chuan Wu; Da-Yong Jin; Wen-Hui Lou; Dan-Song Wang; Xin-Yu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-13       Impact factor: 4.553

4.  Toxoplasma gondii: effect of infection on expression of 14-3-3 proteins in human epithelial cells.

Authors:  Fernando P Monroy
Journal:  Exp Parasitol       Date:  2007-08-03       Impact factor: 2.011

5.  The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy.

Authors:  Xuefeng Wang; Lei Zhang; Ying Chi; Jason Hoellwarth; Sha Zhou; Xiaoyun Wen; Lei He; Feng Liu; Calvin Wu; Chuan Su
Journal:  Parasit Vectors       Date:  2010-11-19       Impact factor: 3.876

6.  DNA vaccines: designing strategies against parasitic infections.

Authors:  Catherine Ivory; Kris Chadee
Journal:  Genet Vaccines Ther       Date:  2004-12-03

Review 7.  Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.

Authors:  Rachel Stephenson; Hong You; Donald P McManus; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2014-09-02

8.  Evaluation of the Schistosoma mansoni Y-box-binding protein (SMYB1) potential as a vaccine candidate against schistosomiasis.

Authors:  Sílvia R C Dias; Mariana Boroni; Elizângela A Rocha; Thomaz L Dias; Daniela de Laet Souza; Fabrício M S Oliveira; Mainá Bitar; Andrea M Macedo; Carlos R Machado; Marcelo V Caliari; Glória R Franco
Journal:  Front Genet       Date:  2014-06-11       Impact factor: 4.599

9.  Protective effects of membrane-anchored and secreted DNA vaccines encoding fatty acid-binding protein and glutathione S-transferase against Schistosoma japonicum.

Authors:  Yaqin Tu; Yang Hu; Guorun Fan; Zhihao Chen; Lin Liu; Dandan Man; Shuojie Liu; Chengwu Tang; Yin Zhang; Wuxing Dai
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

Review 10.  Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis.

Authors:  Evaristus Chibunna Mbanefo; Nguyen Tien Huy; Anita Akpeedje Wadagni; Christine Ifeoma Eneanya; Obioma Nwaorgu; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.